These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 12803217)

  • 21. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications].
    Bessa X; Piñol V; Elizalde JI; Castells A
    Gastroenterol Hepatol; 2000 Dec; 23(10):483-90. PubMed ID: 11149225
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclooxygenase inhibition in patients with coronary artery disease.
    Frishman WH
    J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
    [No Abstract]   [Full Text] [Related]  

  • 23. COX-2 inhibition: not too hot, not too cold--(perhaps) just right?
    Bakowsky V; Hanly JG
    J Rheumatol; 2000 Dec; 27(12):2734-7. PubMed ID: 11128655
    [No Abstract]   [Full Text] [Related]  

  • 24. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
    Baigent C; Patrono C
    Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of cancer and Alzheimer disease with non-steroidal anti-inflammatory agents].
    Marks F
    Dtsch Med Wochenschr; 2001 Mar; 126(11):308-13. PubMed ID: 11296571
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H; Arber N
    Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyamines and cancer: old molecules, new understanding.
    Gerner EW; Meyskens FL
    Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 30. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
    Altinoz MA; Korkmaz R
    Neoplasma; 2004; 51(4):239-47. PubMed ID: 15254653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin and other anti-inflammatory drugs.
    Vane SJ
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S3-9. PubMed ID: 10992545
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cyclo-oxygenase 2 inhibitors and cancer].
    André T; Soria JC
    Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclooxygenase-2 and colorectal cancer.
    DuBois RN
    Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
    [No Abstract]   [Full Text] [Related]  

  • 35. Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors.
    Kune GA
    Aust N Z J Surg; 2000 Jun; 70(6):452-5. PubMed ID: 10843404
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin and salicylate: An old remedy with a new twist.
    Wu KK
    Circulation; 2000 Oct; 102(17):2022-3. PubMed ID: 11044413
    [No Abstract]   [Full Text] [Related]  

  • 37. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.
    Bertagnolli MM
    J Surg Oncol; 2003 Nov; 84(3):113-9. PubMed ID: 14598353
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclooxygenease-2 and hepatocellular carcinoma: is it a target for prevention?
    DuBois RN
    Clin Cancer Res; 2001 May; 7(5):1110-1. PubMed ID: 11350871
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
    Masmoudi A; Chevalier TL; Sabatier L; Soria JC
    Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cyclo-oxygenase 2 in cancer].
    Saukkonen K; Narko K; Ristimäki A
    Duodecim; 1999; 115(8):855-6. PubMed ID: 11859518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.